Tag: Novavax

A new study suggests that repeat Covid vaccinations may lead to a less effective immune response, making individuals more susceptible to repeat infections due to the emergence of specific antibodies called IgG4.

The U.K. has approved a fifth COVID-19 vaccine, developed by U.S. company Novavax, which uses established vaccine technology rather than mRNA or another novel genetic approach.